Imagion Biosystems Limited (IBX.AX)
AUD 0.01
(0.0%)
AUD 0.01
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 750 Thousand AUD | -78.95% |
| 2022 | 3.56 Million AUD | 11440.36% |
| 2021 | 30.87 Thousand AUD | -89.8% |
| 2020 | 302.74 Thousand AUD | -50.77% |
| 2019 | 615.01 Thousand AUD | 3236.33% |
| 2018 | 18.43 Thousand AUD | -62.63% |
| 2017 | 49.32 Thousand AUD | 0.0% |
| 2016 | - AUD | -100.0% |
| 2015 | 3.43 Million AUD | 12.36% |
| 2014 | 3.05 Million AUD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | - AUD | 0.0% |
| 2024 Q1 | - AUD | -100.0% |
| 2023 Q2 | 3.11 Million AUD | 0.0% |
| 2023 Q1 | 3.11 Million AUD | -12.7% |
| 2023 Q4 | 750 Thousand AUD | -76.87% |
| 2023 Q3 | 3.24 Million AUD | 4.25% |
| 2023 FY | 750 Thousand AUD | -78.95% |
| 2022 Q4 | 3.56 Million AUD | 0.0% |
| 2022 Q2 | 3.99 Million AUD | 0.0% |
| 2022 FY | 3.56 Million AUD | 11440.36% |
| 2022 Q3 | 3.56 Million AUD | -10.71% |
| 2022 Q1 | 3.99 Million AUD | 12825.21% |
| 2021 Q1 | 37.91 Thousand AUD | -87.48% |
| 2021 FY | 30.87 Thousand AUD | -89.8% |
| 2021 Q2 | 37.91 Thousand AUD | 0.0% |
| 2021 Q4 | 30.87 Thousand AUD | 0.0% |
| 2021 Q3 | 30.87 Thousand AUD | -18.57% |
| 2020 Q4 | 302.74 Thousand AUD | 0.0% |
| 2020 Q1 | 451.48 Thousand AUD | -26.59% |
| 2020 Q2 | 451.48 Thousand AUD | 0.0% |
| 2020 FY | 302.74 Thousand AUD | -50.77% |
| 2020 Q3 | 302.74 Thousand AUD | -32.94% |
| 2019 Q3 | 615.01 Thousand AUD | 3215.11% |
| 2019 Q1 | 18.55 Thousand AUD | 0.64% |
| 2019 FY | 615.01 Thousand AUD | 3236.33% |
| 2019 Q2 | 18.55 Thousand AUD | 0.0% |
| 2019 Q4 | 615.01 Thousand AUD | 0.0% |
| 2018 Q3 | 18.43 Thousand AUD | -64.59% |
| 2018 Q1 | 52.05 Thousand AUD | 5.53% |
| 2018 FY | 18.43 Thousand AUD | -62.63% |
| 2018 Q4 | 18.43 Thousand AUD | 0.0% |
| 2018 Q2 | 52.05 Thousand AUD | 0.0% |
| 2017 Q1 | 66.63 Thousand AUD | 0.0% |
| 2017 Q4 | 49.32 Thousand AUD | 0.0% |
| 2017 Q3 | 49.32 Thousand AUD | -25.97% |
| 2017 Q2 | 66.63 Thousand AUD | 0.0% |
| 2017 FY | 49.32 Thousand AUD | 0.0% |
| 2016 FY | - AUD | -100.0% |
| 2015 FY | 3.43 Million AUD | 12.36% |
| 2014 FY | 3.05 Million AUD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Australian Clinical Labs Limited | 55.06 Million AUD | 98.638% |
| BCAL Diagnostics Limited | 400.22 Thousand AUD | -87.396% |
| Genetic Signatures Limited | - AUD | -Infinity% |
| Genetic Technologies Limited | - AUD | -Infinity% |
| Healius Limited | 420.8 Million AUD | 99.822% |
| Integral Diagnostics Limited | 219.75 Million AUD | 99.659% |
| INOVIQ Ltd | - AUD | -Infinity% |
| Microba Life Sciences Limited | - AUD | -Infinity% |
| Monash IVF Group Limited | 59.56 Million AUD | 98.741% |
| Rhythm Biosciences Limited | - AUD | -Infinity% |
| Sonic Healthcare Limited | 2.69 Billion AUD | 99.972% |